Target intelligence / Profile preview

Bacterial outer membrane lipopolysaccharide and phospholipids (LPS/PL)

Target
LPS/PL
Molecular classification
Glycolipid, Phospholipid, Bacterial cell wall component, Other
01

Overview

The bacterial outer membrane (OM) of Gram-negative bacteria is a specialized asymmetric bilayer that serves as the first line of defense against environmental threats and antibiotics (Nature Reviews Microbiology, 2010). It is primarily composed of phospholipids in the inner leaflet and lipopolysaccharides (LPS) in the outer leaflet, which provide a robust permeability barrier (NCBI Bookshelf, 2023). LPS, often referred to as endotoxin, consists of three distinct regions: the hydrophobic Lipid A, a core oligosaccharide, and an O-antigen polysaccharide (StatPearls, 2023). This target is clinically significant because it is the site of action for last-resort antibiotics like polymyxins, which disrupt the membrane by binding to the anionic Lipid A component (PubMed, 2019). Beyond its structural role, LPS is a potent inducer of the innate immune response through the TLR4 receptor complex, making it a central player in the pathogenesis of sepsis and septic shock (Nature Reviews Immunology, 2013). Targeting the OM lipids or the transport machinery represents a key strategy for developing new treatments against multi-drug resistant Gram-negative pathogens (Journal of Biological Chemistry, 2017). Resistance to drugs targeting this structure often involves modifications to the Lipid A phosphate groups, which reduces the binding affinity of cationic antibiotics (Frontiers in Microbiology, 2020).

Other names
EndotoxinLipoglycanOuter membrane lipidsLipid AGram-negative outer membrane
02

Mechanism of action

Cationic antibiotics like polymyxins bind to the negatively charged phosphate groups of Lipid A and phospholipids, displacing stabilizing divalent cations (Ca2+ and Mg2+), which leads to increased membrane permeability, leakage of cytoplasmic contents, and cell death (StatPearls, 2023).

03

Biological functions

Immune responseCell deathStructural integrityPermeability barrierOther
04

Disease associations

InfectionInflammationOther
05

Safety considerations

NephrotoxicityNeurotoxicityJarisch-Herxheimer reactionEndotoxin-mediated systemic inflammation
06

Interacting drugs

Polymyxin B

4 more in the full profile.

07

Biomarkers

Endotoxin levelsProcalcitoninC-reactive proteinLPS-binding protein (LBP)

Beyond the preview

Go deeper on Bacterial outer membrane lipopolysaccharide and phospholipids (LPS/PL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial outer membrane lipopolysaccharide and phospholipids (LPS/PL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call